QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Los Angeles, CA -- (SBWire) -- 11/24/2018 --This report studies the global Glucagon Like Peptide-1 (GLP-1) Agonists market status and forecast, categorizes the global Glucagon Like Peptide-1 (GLP-1) Agonists market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.

The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28% in 2015.

Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/506190/global-glucagon-like-peptide-1-glp-1-agonists-market

The global Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at 5240 million US$ in 2017 and will reach 14200 million US$ by the end of 2025, growing at a CAGR of 13.3% during 2018-2025.

The major manufacturers covered in this report

Novo Nordisk

AstraZeneca

Eli Lilly

GSK

Sanofi

Bristol-Myers Squibb

Amylin

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America

Europe

China

Japan

Southeast Asia

India

Buy Full market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/ed7f0a295bcb250d186a199cac13ac35,0,1,Global%20Glucagon%20Like%20Peptide-1%20GLP-1%20Agonists%20Market%20Research%20Report%202018

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.